Sight Sciences (SGHT) Shares Outstanding (Weighted Average) (2020 - 2026)
Sight Sciences (SGHT) recorded quarterly Shares Outstanding (Weighted Average) of $53.9 million in Q1 2026, up 3.44% quarter-over-quarter from $52.1 million in Q4 2025, and up 5.17% on a YoY basis from $51.3 million in Q1 2025.
Sight Sciences (SGHT) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Sight Sciences' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $53.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 5.17% year-over-year to $53.9 million; the TTM figure through Mar 2026 stood at $53.9 million (up 5.17% YoY), while the FY2025 annual figure was $52.1 million, up 4.02% from the prior year.
- Shares Outstanding (Weighted Average) was $53.9 million for Q1 2026 at Sight Sciences, up from $52.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $53.9 million in Q1 2026 to a low of $47.6 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $49.8 million across 5 years, with a median of $49.5 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) jumped 399.82% in 2022, then climbed 1.59% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $47.8 million in 2022, then climbed by 1.63% to $48.6 million in 2023, then rose by 3.1% to $50.1 million in 2024, then advanced by 4.02% to $52.1 million in 2025, then rose by 3.44% to $53.9 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $53.9 million (Q1 2026), $52.1 million (Q4 2025), and $51.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Sight Sciences | 284.28 Mn | 199.32 Mn | 16.98 Mn | 53.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.94 Mn |
| Dec 31, 2025 | 52.15 Mn |
| Sep 30, 2025 | 51.83 Mn |
| Jun 30, 2025 | 51.56 Mn |
| Mar 31, 2025 | 51.29 Mn |
| Dec 31, 2024 | 50.13 Mn |
| Sep 30, 2024 | 50.34 Mn |
| Jun 30, 2024 | 49.90 Mn |
| Mar 31, 2024 | 49.49 Mn |
| Dec 31, 2023 | 48.63 Mn |
| Sep 30, 2023 | 48.67 Mn |
| Jun 30, 2023 | 48.47 Mn |
| Mar 31, 2023 | 48.41 Mn |
| Dec 31, 2022 | 47.85 Mn |
| Sep 30, 2022 | 47.91 Mn |
| Jun 30, 2022 | 47.70 Mn |
| Mar 31, 2022 | 47.57 Mn |
| Dec 31, 2021 | 26.73 Mn |
| Sep 30, 2021 | 19.77 Mn |
| Jun 30, 2021 | 9.56 Mn |